关键信息
-
基因名
RASL11A
- 应用
-
别名
Ras-like protein family member 11A; RAS-like. family 11. member A; Rasl11a; RSLBA_HUMAN
-
种属
Human
-
表达系统
E. coli
-
标签
His tag N-Terminus
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
Q6T310
-
表达区间
1-242 aa
-
氨基酸序列
MRPLSMSGHF LLAPIPESSS DYLLPKDIKL AVLGAGRVGK SAMIVRFLTK RFIGDYEPNT GKLYSRLVYV EGDQLSLQIQ DTPGGVQIQD SLPQVVDSLS KCVQWAEGFL LVYSITDYDS YLSIRPLYQH IRKVHPDSKA PVIIVGNKGD LLHARQVQTQ DGIQLANELG SLFLEISTSE NYEDVCDVFQ HLCKEVSKMH GLSGERRRAS IIPRPRSPNM QDLKRRFKQA LSPKVKAPSA LG
-
分子量
27.0 kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
质检流程
相关产品
背景信息
RASL11A, a member of the RAS superfamily of small GTPases, has garnered attention due to its potential roles in cellular signaling, proliferation, and differentiation processes. As a recently identified protein, it displays unique structural and functional characteristics that distinguish it from other RAS family members. Initial studies suggest that RASL11A may play significant roles in various biological processes, including cell cycle regulation and oncogenesis, making it a candidate of interest in cancer research. Researchers are particularly focused on understanding its mechanisms of action and interactions with downstream effectors, as this knowledge could lead to novel therapeutic strategies for targeting Ras-related signaling pathways in diseases. The development of recombinant RASL11A protein has enabled scientists to investigate its properties in vitro, providing insights into its biochemical functions and potential implications in cell biology. Given the growing evidence linking RAS proteins to tumorigenesis and their challenging nature as drug targets, RASL11A represents a promising area for exploration in both fundamental research and clinical applications aimed at understanding and combating cancer.
